Planet 13 Holdings (PLNH) Cost of Revenue (2021 - 2026)
Planet 13 Holdings (PLNH) reported Cost of Revenue of $11.7 million for Q1 2026, up 654.91% year-over-year from $1.5 million in Q1 2025, and up 124.0% quarter-over-quarter from -$48.7 million in Q4 2025.
Planet 13 Holdings (PLNH) Cost of Revenue (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cost of Revenue data on file, last reported at $11.7 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $11.7 million, up 654.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$21.6 million (down 197.59% YoY), and the FY2025 annual result was $870288.0, down 85.01% from the prior year.
- Cost of Revenue rose to $11.7 million in Q1 2026 per PLNH's latest filing, from -$48.7 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $15.5 million in Q3 2024 and troughed at -$48.7 million in Q4 2025.
- A 5-year average of -$1.2 million and a median of $1.1 million in 2022 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2023 and 2025: Cost of Revenue slumped 3836.44% in 2023, then jumped 15231.24% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $1.1 million in 2022, then tumbled by 3836.44% to -$40.2 million in 2023, then surged by 112.47% to $5.0 million in 2024, then tumbled by 1071.28% to -$48.7 million in 2025, then surged by 124.0% to $11.7 million in 2026.
- Business Quant data shows PLNH's Cost of Revenue at $11.7 million in Q1 2026, -$48.7 million in Q4 2025, and $200787.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.68 Mn |
| Mar 31, 2026 | 11.68 Mn |
| Dec 31, 2025 | -48.66 Mn |
| Dec 31, 2025 | -48.66 Mn |
| Sep 30, 2025 | 200,787.00 |
| Sep 30, 2025 | 200,787.00 |
| Jun 30, 2025 | 15.20 Mn |
| Jun 30, 2025 | 15.20 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Dec 31, 2024 | 5.01 Mn |
| Sep 30, 2024 | 15.46 Mn |
| Sep 30, 2024 | 15.46 Mn |
| Jun 30, 2024 | 99,117.00 |
| Jun 30, 2024 | 99,117.00 |
| Mar 31, 2024 | 12.39 Mn |
| Mar 31, 2024 | 12.39 Mn |
| Dec 31, 2023 | -40.18 Mn |
| Dec 31, 2023 | -40.18 Mn |